Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Weekly intermittent treatment: caution.

J S James

    AIDS Treatment News
    |August 13, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Researchers are exploring intermittent antiretroviral therapy (ART) to reduce drug dosages. This strategy, tested in a small trial, requires patients to have well-controlled viral loads to prevent drug resistance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ability of palatable food consumption to buffer against the short- and long-term behavioral consequences of social defeat exposure during juvenility in rats.

    Physiology & behavior·2017
    Same author

    Effects of electroconvulsive seizures on depression-related behavior, memory and neurochemical changes in Wistar and Wistar-Kyoto rats.

    Progress in neuro-psychopharmacology & biological psychiatry·2014
    Same author

    The effects of rewarding ventral tegmental area stimulation and environmental enrichment on lipopolysaccharide-induced sickness behavior and cytokine expression in female rats.

    Brain research·2008
    Same author

    Behavioral and physiological effects of a single injection of rat interferon-alpha on male Sprague-Dawley rats: a long-term evaluation.

    Brain research·2006
    Same author

    Testosterone cream available at CPS; gel approved by FDA.

    AIDS treatment news·2003
    Same author

    Fluconazole: Pfizer asked to lower Africa price.

    AIDS treatment news·2003
    Same journal

    New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.

    AIDS treatment news·2008
    Same journal

    Flu shot reminder.

    AIDS treatment news·2008
    Same journal

    AIDS search engine wanted: what to do now?

    AIDS treatment news·2007
    Same journal

    Is cure possible for HIV?

    AIDS treatment news·2007
    Same journal

    Financial accounts that can reproduce, inherit, and evolve.

    AIDS treatment news·2007
    Same journal

    Selling digital art in bulk through prepaid URLs.

    AIDS treatment news·2007
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Virology
    • Pharmacology

    Background:

    • Dr. Anthony Fauci discussed novel strategies for reducing antiretroviral therapy (ART) requirements.
    • A small clinical trial investigated intermittent ART administration (every other week).

    Discussion:

    • The trial involved five patients with pre-existing, well-controlled viral loads.
    • Maintaining undetectable viral loads during drug-free intervals is crucial for this approach.
    • The risk of developing drug resistance is a significant consideration.

    Key Insights:

    • Intermittent ART may reduce overall drug exposure in select patient populations.
    • Successful implementation hinges on stringent viral load control before and during treatment.
    • This strategy's applicability to broader patient groups requires further investigation.

    Related Experiment Videos

    Outlook:

    • Further research is needed to assess the long-term efficacy and safety of intermittent ART.
    • Identifying patient subgroups suitable for this reduced-dosage regimen is a key future direction.
    • Understanding resistance development under intermittent dosing is critical for clinical guidelines.